Your email has been successfully added to our mailing list.

×
0 0 0 0 0 -0.0202020202020202 -0.028107158541941 -0.0321080368906455
Stock impact report

Retrophin Doses First Patient in Pivotal Phase 3 PROTECT Study of Sparsentan for the Treatment of IgA Nephropathy

RETROPHIN INC (RTRX) 
Last retrophin inc earnings: 2/24 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.retrophin.com/investor-relations
Company Research Source: GlobeNewswire
SAN DIEGO, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that the first patient has been dosed in the PROTECT Study, a global, pivotal Phase 3 clinical trial evaluating the long-term nephroprotective potential of sparsentan for the treatment of IgA nephropathy (IgAN), a rare kidney disorder that often leads to end-stage renal disease (ESRD). “With no approved therapies indicated for IgA nephropathy, dosing the first patient in the pivotal PROTECT Study brings us closer to our goal of ultimately delivering sparsentan as the first approved therapy for patients living with this rare disorder,” said Noah Rosenberg, M.D., chief medical officer of Retrophin. “The pivotal DUPLEX Study of sparsentan in FSGS is also underway, and the achievement of this latest milestone further underscores our commitment to investigating sparsentan’s potential as a first-in-class therapy for patients with rare kidney disorders. We look forward to working with the IgA nep Show less Read more
Impact Snapshot
Event Time:
RTRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for RTRX alerts
Opt-in for
RTRX alerts

from News Quantified
Opt-in for
RTRX alerts

from News Quantified